Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v4-EN
Language English English
Date Updated 2024-04-03 2024-04-30
Drug Identification Number 02325756 02325756
Brand name SANDOZ TRANDOLAPRIL SANDOZ TRANDOLAPRIL
Common or Proper name TRANDOLAPRIL TRANDOLAPRIL
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients TRANDOLAPRIL TRANDOLAPRIL
Strength(s) 2MG 2MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100HGC BO 100HGC BO
ATC code C09AA C09AA
ATC description ACE INHIBITORS, PLAIN ACE INHIBITORS, PLAIN
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-04-02 2024-04-02
Estimated end date 2024-05-31 2024-06-14
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments